TY - CHAP M1 - Book, Section TI - Deep Venous Thrombosis A1 - Patel, Kinnaresh A1 - Bhugra, Paramveer A1 - Dudney, Tina M. A1 - McCormack, Michael T. A2 - Dieter, Robert S. A2 - Dieter, Raymond A. A2 - Dieter, Raymond A. PY - 2011 T2 - Venous and Lymphatic Diseases AB - Deep venous thrombosis (DVT) is a common disease with potentially serious consequences such as pulmonary embolism (PE). Although the risk without prophylaxis of all venous thromboembolism (VTE) was 15% in one study of medical inpatients, the rate of clinically symptomatic DVT was only 6% (n = 188). VTE represents a potentially fatal disease process with a clinical presentation that is often silent or nonspecific. A substantial number of patients remain at risk as a result of the demographics of an aging population and the ability of modern medicine to treat patients with chronic disease. During the past decade, many of the long-standing controversies surrounding the natural history, diagnosis, and therapy of patients with VTE have been partially or completely reconciled, resulting in substantial changes in the diagnostic and therapeutic approach to the disease. In the evaluation of patients with suspected VTE, an understanding of what is unknown can prove invaluable to the decision-making process. SN - PB - McGraw-Hill Medical CY - New York, NY Y2 - 2024/03/28 UR - accesscardiology.mhmedical.com/content.aspx?aid=1126491801 ER -